The EPS projection of Illumina, Inc. (NASDAQ:ILMN) for quarter ended 2016-09-30 is $0.9. Last week, the EPS forecast was $0.9 against target of $0.9, a month earlier. Two months ago, this estimate was $0.9 versus forecast of $0.9 three months earlier, implying a deviation of 0%.
Illumina, Inc. (NASDAQ:ILMN) stated that 18 days ago, its stock price was positively revised 1 times while negative revisions were 8.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 4, and 1, correspondingly.
EPS estimate downgrade for Illumina, Inc. (NASDAQ:ILMN) in the preceding 30, 120, 60 and 90 days were 0, 9, 5, and 9, correspondingly.
Illumina, Inc. (NASDAQ:ILMN) EPS target for the quarter closed 1 was $0.9, based on 13 recommendations. As reported on 2016-05-03 the EPS was $0.71. The change was $-0.03, implying a percentage deviation of -4.05%. The projections showed a standard deviation of 0.04.
Quarterly Sales Estimates
Illumina, Inc. (NASDAQ:ILMN) yearly sales prediction for the fiscal 2017 stands at $772.555 and the median estimate is at $772.555. Almost 2 analysts issued sales target.
Highest sales target is $809.111 while the lowest target is $736 showing standard deviation of 51.697%.
As many as 2 analysts have sales targets revised upside while 2 reduced sales estimates, implying a deviation of 0%.
Last month, 2 revised sales number projection on upside while 2 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast. Illumina, Inc. (NASDAQ:ILMN) announced that the deviation in forecast was -3.175%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...